Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:42 pm Purchase |
2024-12-31 | 13G | Ekso Bionics Holdings, Inc. EKSO |
Armistice Capital, LLC | 10,000 9.990% |
255 (+2.61%) |
Filing History |
| 2025-02-14 5:42 pm Sale |
2024-12-31 | 13G | Edible Garden AG Incorporated EDBL |
Armistice Capital, LLC | 79,793 9.990% |
-2,298 (-2.80%) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 276,422 9.990% |
90,211 (+48.45%) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | DANIMER SCIENTIFIC INC DNMRQ |
Armistice Capital, LLC | 171,761 5.500% |
171,761 (New Position) |
Filing History |
| 2025-02-14 5:41 pm Purchase |
2024-12-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF |
Armistice Capital, LLC | 478,547 9.990% |
70,437 (+17.26%) |
Filing History |
| 2025-02-14 5:40 pm Purchase |
2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Armistice Capital, LLC | 52,606 9.990% |
38,690 (+278.03%) |
Filing History |
| 2025-02-14 5:39 pm Purchase |
2024-12-31 | 13G | Cosmos Health Inc. COSM |
Armistice Capital, LLC | 2,508,013 9.990% |
359,825 (+16.75%) |
Filing History |
| 2025-02-14 5:38 pm Purchase |
2024-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT |
Armistice Capital, LLC | 5,216,445 9.990% |
642,699 (+14.05%) |
Filing History |
| 2025-02-14 5:36 pm Sale |
2024-12-31 | 13G | Iveda Solutions, Inc. IVDA |
Armistice Capital, LLC | 139,603 4.990% |
-96,660 (-40.91%) |
Filing History |
| 2025-02-14 5:36 pm Purchase |
2024-12-31 | 13G | Iterum Therapeutics plc ITRM |
Armistice Capital, LLC | 1,445,158 4.990% |
105,158 (+7.85%) |
Filing History |
| 2025-02-14 5:35 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Armistice Capital, LLC | 3,529,006 4.990% |
2,770,121 (+365.03%) |
Filing History |
| 2025-02-14 5:35 pm Purchase |
2024-12-31 | 13G | T Stamp Inc. IDAI |
Armistice Capital, LLC | 1,397,878 4.990% |
1,397,878 (New Position) |
Filing History |
| 2025-02-14 5:35 pm Sale |
2024-12-31 | 13G | GeoVax Labs, Inc. GOVX |
Armistice Capital, LLC | 495,589 4.990% |
-450,548 (-47.62%) |
Filing History |
| 2025-02-14 5:34 pm Purchase |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 3,137,553 4.990% |
773,553 (+32.72%) |
Filing History |
| 2025-02-14 5:33 pm Sale |
2024-12-31 | 13G | Clene Inc. CLNN |
Armistice Capital, LLC | 419,101 4.990% |
-280,899 (-40.13%) |
Filing History |
| 2025-02-14 5:33 pm Sale |
2024-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Armistice Capital, LLC | 440,422 4.990% |
-238,108 (-35.09%) |
Filing History |
| 2025-02-14 5:32 pm Purchase |
2024-12-31 | 13G | Banzai International, Inc. BNZI |
Armistice Capital, LLC | 309,096 4.990% |
148,066 (+91.95%) |
Filing History |
| 2025-02-14 5:31 pm Purchase |
2024-12-31 | 13G | Mustang Bio, Inc. MBIO |
Armistice Capital, LLC | 5,106,287 9.990% |
5,106,287 (New Position) |
Filing History |
| 2025-02-14 5:30 pm Purchase |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
Armistice Capital, LLC | 5,800,000 7.460% |
5,800,000 (New Position) |
Filing History |
| 2025-02-14 5:30 pm Purchase |
2024-12-31 | 13G | Professional Diversity Network, Inc. IPDN |
Armistice Capital, LLC | 133,418 9.990% |
133,418 (New Position) |
Filing History |